Anupama Pasam
Melbourne Austin Branch
Melbourne, VIC, Australia
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Recurrent intra-tumour heterogeneity is a hallmark of metastatic prostate cancer.
Journal: Nature communications
Published: November 21, 2025
[177Lu]Lu-PSMA-617 in combination with pembrolizumab for treatment of metastatic castration resistant prostate cancer (PRINCE): a single-arm, phase 1b/2 study.
Journal: The Lancet. Oncology
Published: October 07, 2025
Detection of PSMA expression on circulating tumor cells by blood-based liquid biopsy in prostate cancer.
Journal: Journal of circulating biomarkers
Published: July 18, 2023
Copy number architectures define treatment-mediated selection of lethal prostate cancer clones.
Journal: Nature communications
Published: June 02, 2022
Spatial analysis with SPIAT and spaSim to characterize and simulate tissue microenvironments.
Journal: Nature communications
Published: May 05, 2022
Tumor immune microenvironment of primary prostate cancer with and without germline mutations in homologous recombination repair genes.
Journal: Journal for immunotherapy of cancer
Published: April 14, 2022
Ropporin-1 and 1B Are Widely Expressed in Human Melanoma and Evoke Strong Humoral Immune Responses.
Journal: Cancers
Published: March 22, 2021
Autoantibodies May Predict Immune-Related Toxicity: Results from a Phase I Study of Intralesional Bacillus Calmette-Guérin followed by Ipilimumab in Patients with Advanced Metastatic Melanoma.
Journal: Frontiers in immunology
Published: December 15, 2017
Last Updated: 09/26/2026